Abstract:Abstract Levosimendan and dobutamine are extensively used to treat sepsis-associated cardiovascular failure in ICU. Nevertheless, the role and mechanism of levosimendan in patients with sepsis-induced cardiomyopathy remains unclear. Moreover, previous studies on whether levosimendan is superior to dobutamine are still controversial. More importantly, these studies did not take changes (before-after comparison to the baseline) in quantitative parameters such as ejection fraction into account with the baseline level. Here, we aimed to determine the pros and cons of the two medicines by assessing the changes in cardiac function and blood lactate, mortality, with the standardized mean difference used as a summary statistic. Relevant studies were obtained by a thorough and disciplined literature search in several notable academic databases, including Google Scholar, PubMed, Cochrane Library and Embase until November 2020. Outcomes included changes in cardiac function, lactic acid, mortality and length of hospital stay. A total of 6 randomized controlled trials were included in this study, including 192 patients. Compared with dobutamine, patients treated with levosimendan had a greater improvement of cardiac index (ΔCI) (random effects, SMD = 0.90 [0.20,1.60]; I 2 = 76%, P < 0.01) and left ventricular stroke work index (ΔLVSWI) (random effects, SMD = 1.56 [0.90,2.21]; I 2 = 65%, P = 0.04), a significant decrease of blood lactate (Δblood lactate) (random effects, MD = − 0.79 [− 1.33, − 0.25]; I 2 = 68%, P < 0.01) at 24-h after drug intervention, respectively. There was no significant difference between levosimendan and dobutamine on all-cause mortality in ICU (fixed effect, OR = 0.72 [0.39,1.33]; I 2 = 0%, P = 0.99). We combine effect sizes related to different measurement parameters to evaluate cardiac function, which implied that septic patients with myocardial dysfunction might have a better improvement of cardiac function by levosimendan than dobutamine (random effects, SMD = 1.05 [0.69,1.41]; I 2 = 67%, P < 0.01). This study suggested a significant improvement of CI, LVSWI, and decrease of blood lactate in septic patients with myocardial dysfunction in ICU after 24-h administration of levosimendan than dobutamine. However, the administration of levosimendan has neither an impact on mortality nor LVEF. Septic patients with myocardial dysfunction may partly benefit from levosimendan than dobutamine, mainly embodied in cardiac function improvement.

The effect of dobutamine vs milrinone in sepsis: A big data, real‐world study

The Effect of Dobutamine in Sepsis: a Propensity Score Matched Analysis

Comparison of Outcomes Between Milrinone and Dobutamine in Patients With Cardiogenic Shock: A Meta-Analysis of Randomized Control Trials and Observational Studies

Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.

Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure

Milrinone vs Dobutamine for the Management of Cardiogenic Shock: Implications of Renal Function and Injury

The effect of intravenous milrinone in adult critically ill patients: A meta-analysis of randomized clinical trials

Levosimendan versus dobutamine for sepsis-induced cardiac dysfunction: a systematic review and meta-analysis

The Hemodynamic Effects of Milrinone in Patients with Sepsis and Low Cardiac Output

Do the observational studies using propensity score analysis agree with randomized controlled trials in the area of sepsis?

The Effect of Milrinone on Mortality in Adult Patients Who Underwent CABG Surgery: A Systematic Review of Randomized Clinical Trials with a Meta-Analysis and Trial Sequential Analysis

Prevention of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery: A Double-Blind Randomized Clinical Pilot Study Comparing Dobutamine and Milrinone

Effect of dobutamine on extravascular lung water index, ventilator function, and perfusion parameters in acute respiratory distress syndrome associated with septic shock

Effect of milrinone on cardiac functions in patients undergoing coronary artery bypass graft: a meta-analysis of randomized clinical trials.

Effect of Levosimendan on Mortality in Severe Sepsis and Septic Shock: a Meta-Analysis of Randomised Trials

Patient Attributes Associated With Better Long-Term Outcomes on Palliative Milrinone

Efficacy and safety of levosimendan in patients with sepsis: a systematic review and network meta-analysis

Comparative Effectiveness and Safety of Milrinone and Levosimendan as Initial Inotrope Therapy in Patients With Acute Heart Failure With Renal Dysfunction

Combination therapy of milrinone and esmolol on heart function, inflammatory factors and prognosis of sepsis patients

Effect of dobutamine on intrinsic myocardial function and myocardial apoptosis in septic rats with myocardial dysfunction

The Long-term Effect of Dobutamine on Intrinsic Myocardial Function and Myocardial Injury in Septic Rats with Myocardial Dysfunction